XML 32 R16.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Segment And Enterprise-Wide Disclosures
6 Months Ended
Jun. 30, 2011
Segment And Enterprise-Wide Disclosures  
Segment And Enterprise-Wide Disclosures

11. Segment and Enterprise-Wide Disclosures

The Financial Accounting Standards Board (the FASB) establishes standards for reporting information regarding operating segments in annual financial statements. Operating segments are identified as components of an enterprise about which separate, discrete financial information is available for evaluation by the chief operating decision-maker in making decisions on how to allocate resources and assess performance. We view our operations and manage our business as one operating segment. No discrete operating information is prepared by us except for product sales by product line and by geographic location for local reporting purposes.

 

Most of our revenues were generated in the United States, Europe, and Japan, and substantially all of our assets are located in the United States. We analyze our sales using a number of approaches, including sales by legal entity. Our German subsidiary (LeMaitre Vascular GmbH) records all sales in Europe excluding direct sales in France (LeMaitre Vascular SAS); Italy (LeMaitre Vascular S.r.l.); and Spain (LeMaitre Spain SL) beginning July 1, 2011, and to distributors worldwide, excluding distributor sales in North, South and Central America (LeMaitre Vascular, Inc.) and Korea, and Taiwan (LeMaitre Vascular GK). Net sales to unaffiliated customers by legal entity were as follows:

 

     Three months ended
June 30,
     Six months ended
June 30,
 
     2011      2010      2011      2010  
     (in thousands)  

LeMaitre Vascular, Inc.

   $ 9,415       $ 8,872       $ 18,417       $ 16,920   

LeMaitre Vascular GmbH

     3,952         3,682         7,687         7,951   

Other entities

     1,745         1,604         3,606         3,102   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 15,112       $ 14,158       $ 29,710       $ 27,973   
  

 

 

    

 

 

    

 

 

    

 

 

 

We sell products in three product categories, Vascular, Endovascular, and Other. Net sales in these product categories were as follows:

 

     Three months ended
June 30,
     Six months ended
June 30,
 
     2011      2010      2011      2010  
     (in thousands)  

Vascular

   $ 11,436       $ 10,207       $ 22,196       $ 19,764   

Endovascular

     2,725         2,944         5,626         6,236   

Other

     951         1,007         1,888         1,973   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 15,112       $ 14,158       $ 29,710       $ 27,973